This federal contract award, with an ID of SPE2DB20D7059|SPE2DB25FPTR1, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4,566,316,375 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine. This is a firm fixed-price Delivery Order contract with a ceiling value of $5,617.92 and an ultimate completion date of November 5, 2024. The contract does not have a set-aside designation, indicating open competition.
Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 2/3/25, 1:13 PM